Found 7 articles for: "Alopecia areata"
Review of Baricitinib in the Treatment of Alopecia Areata
September 2023 | Volume 22 | Issue 9 | Original Article | 935 | Copyright © September 2023
Background: Alopecia areata (AA) is a debilitating autoimmune disease that results in non-scarring hair loss. Baricitinib is the Food and Drug Administration (FDA) approved treat...
Read MoreReview of Superficial Cryotherapy for the Treatment of Alopecia Areata
August 2023 | Volume 22 | Issue 8 | Original Article | 802 | Copyright © August 2023
Cryotherapy has recently been examined as a potential treatment for alopecia areata (AA). AA is classically managed with intralesional or systemic steroids but relapse rates among those with long...
Read MoreRefractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
December 2022 | Volume 21 | Issue 12 | Case Reports | 1366 | Copyright © December 2022
Background: In the last several years, oral tofacitinib has become an increasingly utilized off-label treatment option for immune-mediated skin conditions such as alopecia areata (AA)...
Read MoreThe Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1070 | Copyright © October 2022
Background: Approximately 30% to 40% of alopecia areata (AA) patients have atopic dermatitis. Studies suggest that antihistamines and dupilumab may be effective treatments; however, t...
Read MoreRetrospective Study of Covid Related Hair Loss
July 2022 | Volume 21 | Issue 7 | Original Article | 724 | Copyright © July 2022
The Novel Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus two and primarily affects the epithelium of the airways. Multiple cutaneous manifestations of COVID-...
Read MoreA Case of Late-Onset Alopecia Areata
April 2022 | Volume 21 | Issue 4 | Case Reports | 420 | Copyright © April 2022
Alopecia areata (AA) is a condition characterized by nonscarring hair loss. Cases of alopecia areata are most commonly seen in patients under age 30 and are frequently idiopathic. In this report, we d...
Read MoreSuccessful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib
July 2018 | Volume 17 | Issue 7 | Case Reports | 800 | Copyright © July 2018
Alopecia areata is an autoimmune disease involving the hair follicle with a chronic, relapsing course. Tofacitinib...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.